A Study of Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT05461209 · WITHDRAWN
Trial details
- NCT number
- NCT05461209
- Sponsor
- Janssen Research & Development, LLC
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-20
- Primary completion
- 2022-11-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.